— Know what they know.
Not Investment Advice

RCKT NASDAQ

Rocket Pharmaceuticals, Inc.
1W: -8.5% 1M: -18.2% 3M: -17.7% YTD: -10.1% 1Y: -54.6% 3Y: -85.5% 5Y: -92.4%
$2.96
-0.15 (-4.82%)
 
Weekly Expected Move ±7.9%
$3 $3 $3 $4 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $323.2M mcap · 88M float · 3.89% daily turnover · Short 58% of daily vol

Cash Flow Trends

Operating Cash Flow
-$190M +9.4% ▲
Capital Expenditures
$440K +92.5% ▲
5Y CAGR: -56.7%
Free Cash Flow
-$190M +11.7% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$86M -179.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$169M-$222M-$246M-$259M-$223M
Depreciation & Amort.$5M$6M$7M$9M$11M
Stock-Based Comp.$29M$31M$39M$44M$37M
Change in Working Capital-$3M$6M$13M$2M-$8M
Other Non-Cash Items$14M$370K-$9M-$6M-$7M
Operating Cash Flow-$121M-$178M-$195M-$210M-$190M
— Investing Activities —
Capital Expenditures-$8M-$9M-$16M-$6M-$440K
Acquisitions (Net)$95K$43M$0$0$0
Investment Purchases-$246M-$376M-$391M-$246M-$277M
Investment Sales$272M$273M$309M$383M$381M
Other Investing-$95K$0$0$0$0
Investing Cash Flow$19M-$69M-$98M$132M$104M
— Financing Activities —
Net Debt Issuance$201K$172K$139K$0$35K
Stock Repurchased$0-$47K$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$201K-$172K-$132K$0$113K
Financing Cash Flow$38M$155M$208M$186M$148K
Net Change in Cash-$65M-$92M-$85M$108M-$86M
Cash End of Period$234M$142M$57M$165M$79M
Free Cash Flow-$129M-$187M-$211M-$216M-$190M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms